Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 440-850-3 | CAS number: 27311-52-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Dermal absorption
Administrative data
- Endpoint:
- dermal absorption in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study and GLP
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 428 (Skin Absorption: In Vitro Method)
- Deviations:
- not specified
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- -
- EC Number:
- 440-850-3
- EC Name:
- -
- Cas Number:
- 27311-52-0
- Molecular formula:
- C13H14N2O2.2ClH
- IUPAC Name:
- 4-amino-2-[(5-amino-2-hydroxyphenyl)methyl]phenol dihydrochloride
- Reference substance name:
- [TN]Colipa A 155[/TN][SPEC][/SPEC][AM]95%[/AM]
- IUPAC Name:
- [TN]Colipa A 155[/TN][SPEC][/SPEC][AM]95%[/AM]
- Details on test material:
- SAT 090013
Batch No.: 703
Study No.: 789228
Constituent 1
Constituent 2
- Radiolabelling:
- yes
- Remarks:
- 14C
Test animals
- Species:
- other: dermatomed pig skin
- Strain:
- other: landrace large white cross pig
- Sex:
- male/female
Administration / exposure
- Type of coverage:
- open
- Vehicle:
- other: water or cream formulations with different developer mixed with hydrogen peroxide or without hydrogen peroxide
- Duration of exposure:
- The skin surface was washed at 30 min, for each test preparation, to reflect the in use conditions. The skin was again
washed at 24 h post dose as a final wash off before test run termination.
0.5 hours application time, afterwards test substance was rinsed off. - Doses:
- The hair dye formulation was applied at an application volume of ca 20 mg/cm2. Therefore the resulted dose of the test substance was approx. 0.2 mg/cm2 skin.
- No. of animals per group:
- 12 samples of pig skin from 4 different animals
- Control animals:
- no
Results and discussion
Percutaneous absorptionopen allclose all
- Dose:
- 0.2 mg/cm2
- Parameter:
- percentage
- Absorption:
- 0.64 %
- Remarks on result:
- other: 30 min exposure, amount absorbed and penetrated within 24 h after application
- Remarks:
- Standard formulation with H2O2
- Dose:
- 0.2 mg/cm2
- Parameter:
- percentage
- Absorption:
- 0.92 %
- Remarks on result:
- other: 30 min exposure, amount absorbed and penetrated within 24 h after application
- Remarks:
- Standard formulation without H2O2
- Conversion factor human vs. animal skin:
- No data
Applicant's summary and conclusion
- Conclusions:
- In conclusion, following topical application of [14C]-A155 in hair dye formulation without hydrogen peroxide to pig skin in vitro, the dermal bio-
availability of [14C]-A155 was 0.92% (1.97 μg equiv./cm2) of the applied dose. The majority of the dose was removed by washing the skin.
The mass balance was complete (94.76%) for [14C]-A155 from Test Preparation 1. Following topical application of [14C]-A155 in hair dye formula-
tion with hydrogen peroxide to pig skin in vitro, the dermal bioavailability of [14C]-A155 was 0.64% (1.41 μg equiv./cm2) of the applied dose.
The majority of the dose was removed by washing the skin. The mass balance was complete (100.37%) for [14C]-A155 from Test Preparation 2. - Executive summary:
The test substance, A155, is intended to be used as an ingredient in harr dye formulations. As part of a safety evaluation of this ingredient, this study was required to assess the extent of dermalbioavailability, following topical application of a typical hair colouring formulation with a content of finally 1% (w/w) A155 ([14C]~radiolabelled) to excised dermatomed pig skin. Immediately prior to application, the formulation containing 2% (w/w) A155 was mixed 1:1 (w/w) with developer without hydrogen peroxide (Test Preparation 1) or with developer containing hydrogen peroxide (6%, w/w) (Test Preparation 2). The concentration of A155 in Test Preparations 1 and 2 was ca 1% (w/w). The skin surface was washed 30 min after topical application of each test preparation to reflect the in use conditions. The skin was again washed at 24 h post dose as a final wash off before test run termination.
Previously frozen dermatomed pig skin (12 replicates per test run of 4 individual pigs in total) was mounted into static diffusion cells containing receptor fluid (phosphate buffered saline, ca 10 ml) in the receptor chamber. The skin surface temperature was maintained at ca 32°C throughout the experiment. An electrical resistance barrier integrity test was performed and any pig skin sample exhibiting a resistance <4 kohm was excluded from subsequent dermal bioavailability measurements. The hair dye formulation was applied at an application volume of ca 20 mg/cm2 , to dermatomed pig skin mounted into static diffusion cells in vitro. Dermal bioavailability was assessed by collecting receptor fluid aliquots at 0.5, 1,2,4,6 and 24 h post dose. At 30 min post dose, for both test preparations, exposure was terminated by washing the skin surface with a dilute shampoo solution and drying the skin surface with
tissue paper (tissue swabs). At 24 h post dose, the washing procedure was repeated. The skin was then removed from the static diffusion cells, dried and divided into exposed and unexposed. The stratum comeum was removed from the exposed skin with 20 successive tape strips. The remaining exposed skin was solubilised with Solvable® tissue solubiliser. After the 24 h receptor fluid aliquot was taken, the receptor fluid in the receptor chamber was removed into a bulk: receptor fluid vial and stored at ca ~20°C. All sampies were analysed by liquid scintillation counting.
For hair dye formulation, containing 1 % (w/w) A155 in the absence of hydrogen peroxide applied to dermatomed pig skin in vitro, most of the applied dose of (90.50%) was removed by washing at 30 min post dose. At 24 h post dose, the total dislodgeable dose was 91.86% of the applied dose. The total unabsorbed dose was 91.88% of the applied dose. The stratum corneum (dermal adsorption) retained 1.96% ofthe applied dose. The percutaneous penetration and dermal bioavailability were 0.01 % (0.03 µg equiv./cm2) and 0.92% (1.97 µg equiv./cm2) of the applied dose, respectively. The mass balance was complete with 94.76% (CV: 6.48%) ofthe applied dose recovered.
For hair dye formulation, containing 1 % (w/w) A155 in the presence of hydrogenperoxide applied to dermatomed pig skin in vitro, most of the applied dose (96.78%) was removed by washing at 30 min post dose. At 24 h post dose, the total dislodgeable dose was 97.77% of the applied dose. The total unabsorbed dose was 97.78% ofthe applied dose. The stratum corneum (dermal adsorption) retained 1.95% of the applied dose. The percutaneous penetration and dermal bioavailability were 0.01 % (0.01 µlg equiv./cm ) and 0.64% (1.41 µg equiv./cm2) of the applied dose, respectively. The mass balance was complete with 100.37% (CV: 8.38%) of the applied dose recovered.
In conclusion, following topical application of radiodiluted [14C]-A155 in a typical hair dye formulation without hydrogen peroxide to pig skin in vitro, the dermal bioavailability of [14C]-A155 was 0.92% (1.97 µg equiv./cm2) of the applied dose. The majority of the dose was removed by washing the skin. The mass balance was complete (94.76%) for [14C]-A155 from Test Preparation 1.
Following topical application of radiodiluted [14C]-A155 in a typical hair dye formulation with hydrogen peroxide to pig skin in vitro, the dermal bioavailability of [14C]-A155 was 0.64% (1.41µg equiv./cm2) of the applied dose. The majority ofthe dose was removed by washing the skin. The mass balance was complete (100.37%) for [14C]-A155 from Test Preparation 2.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)